# OnCo record paper-priestley-hartwig-metastatic-wgs-nature-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-priestley-hartwig-metastatic-wgs-nature-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-priestley-hartwig-metastatic-wgs-nature-2019" ;
  schema:name "Whole-genome sequencing of 2,520 metastatic tumours from the Dutch Hartwig cohort"@en ;
  schema:description "The Hartwig Medical Foundation's whole-genome analysis of metastatic cancers from Dutch patients found a variant that could steer treatment towards an approved or trial drug in 62 per cent of them."@en ;
  schema:url <https://onco.cc/key-papers/paper-priestley-hartwig-metastatic-wgs-nature-2019/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41586-019-1689-y>, <https://pubmed.ncbi.nlm.nih.gov/31645765/>, <https://www.hartwigmedicalfoundation.nl/en/data/database/> ;
  schema:sameAs <https://doi.org/10.1038/s41586-019-1689-y> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Priestley P, Baber J, Lolkema MP, et al." ;
  onco:related <https://onco.cc/trials/drup/> ;
  onco:technologies <https://onco.cc/technologies/wes-wgs/> ;
  onco:companies <https://onco.cc/companies/hartwig-medical-foundation/> .